Vivance

Vivance is a medical technology company dedicated to improving the lives of individuals with kidney disease and their caregivers. Formerly known as AWAK Technologies, the company focuses on developing innovative solutions that enhance health outcomes and quality of life for patients with end-stage renal disease. Vivance's flagship product is the Automated Wearable Artificial Kidney (AWAK), a wearable dialysis device that allows for continuous treatment outside of traditional clinical settings. This innovation promotes patient mobility and autonomy. The company also offers cost-effective home dialysis options and digital health solutions, all designed to support comprehensive kidney care. Founded in Singapore in 2007, Vivance has received breakthrough device designations from the U.S. Food and Drug Administration (FDA), highlighting its contributions to kidney health technology. Vivance aims to make wearable and home-based dialysis widely accessible, improving patient quality of life and easing the burden of kidney disease treatment.

• Employees 120
• Founded 2007
• Annual Revenue $6000000
• Total Funding $88400000